Search research articles
Contact Us
Filters
Showing results (411-420 of 549) with videos related to
Page
of 55
Sort By:
Plos One
|
September 26, 2013
Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency
Megan C Hanna, Christina Go, Christine Roden, et al.
Cancer Discovery
|
September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors
Dalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Blood Advances
|
December 21, 2018
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)
Gail J Roboz, Sumithra J Mandrekar, Pinkal Desai, et al.
Science (New York, N.Y.)
|
September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
BMC Cancer
|
April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Neil R Parikh, Claudia Huiza, Jill S Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 6, 2009
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H B Salvesen, S L Carter, M Mannelqvist, et al.
The New England Journal of Medicine
|
October 9, 2014
Response and acquired resistance to everolimus in anaplastic thyroid cancer
Nikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Plos One
|
June 9, 2017
Systematic genomic and translational efficiency studies of uveal melanoma
Chelsea Place Johnson, Ivana K Kim, Bita Esmaeli, et al.
Nature Medicine
|
November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Mirja Rotinen, Sungyong You, Julie Yang, et al.
Nature Biotechnology
|
March 2, 2016
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
Channing Yu, Aristotle M Mannan, Griselda Metta Yvone, et al.
Page
of 55
Search research articles
Search
Showing results (411-420 of 549) with videos related to
Sort By:
Page
of 55
Plos One
|
September 26, 2013
Colorectal cancers from distinct ancestral populations show variations in BRAF mutation frequency
Megan C Hanna, Christina Go, Christine Roden, et al.
Cancer Discovery
|
September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors
Dalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.
Blood Advances
|
December 21, 2018
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)
Gail J Roboz, Sumithra J Mandrekar, Pinkal Desai, et al.
Science (New York, N.Y.)
|
September 12, 2015
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M Van Allen, Diana Miao, Bastian Schilling, et al.
BMC Cancer
|
April 3, 2019
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Neil R Parikh, Claudia Huiza, Jill S Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 6, 2009
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H B Salvesen, S L Carter, M Mannelqvist, et al.
The New England Journal of Medicine
|
October 9, 2014
Response and acquired resistance to everolimus in anaplastic thyroid cancer
Nikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Plos One
|
June 9, 2017
Systematic genomic and translational efficiency studies of uveal melanoma
Chelsea Place Johnson, Ivana K Kim, Bita Esmaeli, et al.
Nature Medicine
|
November 28, 2018
ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
Mirja Rotinen, Sungyong You, Julie Yang, et al.
Nature Biotechnology
|
March 2, 2016
High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
Channing Yu, Aristotle M Mannan, Griselda Metta Yvone, et al.
Page
of 55